Cannasat Therapeutics Appoints Dr. Julia Levy to Board of Directors
January 14, 2008 09:44 ET
|
Cannasat Therapeutics Inc.
TORONTO, Jan. 14, 2008 (PRIME NEWSWIRE) -- Cannasat Therapeutics ("Cannasat" or the "Company") (TSX-V:CTH), the developer of novel cannabinoid-based pharmaceutical products, today announced that Dr....
Cannasat and IntelGenx Complete Phase 1 Study for CAT 310
December 04, 2007 08:25 ET
|
Cannasat Therapeutics Inc.
TORONTO, Dec. 4, 2007 (PRIME NEWSWIRE) -- Cannasat Therapeutics Inc. ("Cannasat") (TSX-V:CTH), a company specializing in the development of cannabinoid-based pharmaceutical products, announced today...
Cannasat Therapeutics Retains Leading Investor Relations Firm
November 08, 2007 08:00 ET
|
Cannasat Therapeutics Inc.
TORONTO, Nov. 8, 2007 (PRIME NEWSWIRE) -- Cannasat Therapeutics (TSX-V:CTH) (the "Company") today announced that it has retained The Equicom Group ("Equicom") to provide the Company with strategic...
Cannasat Therapeutics Appoints George Nomikos as Senior Director, Scientific Affairs
October 30, 2007 07:25 ET
|
Cannasat Therapeutics Inc.
TORONTO, Oct. 30, 2007 (PRIME NEWSWIRE) -- Cannasat Therapeutics (TSX-V:CTH) (the "Company"), the developer of novel cannabinoid-based pharmaceutical products, today announced that George Nomikos,...
Cannasat Therapeutics and IntelGenx Corp. Reach Key Milestone
September 17, 2007 08:55 ET
|
Cannasat Therapeutics Inc.
TORONTO, Sept. 17, 2007 (PRIME NEWSWIRE) -- Cannasat Therapeutics Inc. ("Cannasat") (TSX-V:CTH), a company specializing in the development of cannabinoid-based pharmaceutical products, announced today...
Cannasat Therapeutics Reports Results for the Six Months Ended June 30, 2007
August 28, 2007 10:12 ET
|
Cannasat Therapeutics Inc.
TORONTO, Aug. 28, 2007 (PRIME NEWSWIRE) -- Cannasat Therapeutics Inc. (TSX-V:CTH), the developer of novel cannabinoid-based pharmaceutical products, today announced its results for the six months...
Cannasat Therapeutics to Commence Phase 1 Study of CAT 310, a Potential Treatment for Neuropathic Pain
August 23, 2007 12:06 ET
|
Cannasat Therapeutics Inc.
TORONTO, Aug. 23, 2007 (PRIME NEWSWIRE) -- Cannasat Therapeutics Inc. ("Cannasat") (TSX-V:CTH) announced today that Health Canada has approved Cannasat's clinical trial application for a Phase 1...